Evidence map›Paper›PMID 36234737›Full record

ReviewMolecules (Basel, Switzerland)2022

Herbal Arsenal against Skin Ailments: A Review Supported by In Silico Molecular Docking Studies.

Abdel Nasser B Singab, Nada M Mostafa, Iten M Fawzy, Deepika Bhatia, Pooja Tanaji Suryawanshi, Atul Kabra

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Molecules (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abdel Nasser B SingabDepartment of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.ORCID 0000-0001-7445-963X
Nada M MostafaDepartment of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.ORCID 0000-0003-1602-2725
Iten M FawzyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Future University in Egypt, Cairo 11835, Egypt.
Deepika BhatiaUniversity Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali 140413, Punjab, India.
Pooja Tanaji SuryawanshiUniversity Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali 140413, Punjab, India.
Atul KabraUniversity Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali 140413, Punjab, India.ORCID 0000-0003-2890-1575

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maintaining healthy skin is important for a healthy body. At present, skin diseases are numerous, representing a major health problem affecting all ages from neonates to the elderly worldwide. Many people may develop diseases that affect the skin, including cancer, herpes, and cellulitis. Long-term conventional treatment creates complicated disorders in vital organs of the body. It also imposes socioeconomic burdens on patients. Natural treatment is cheap and claimed to be safe. The use of plants is as old as mankind. Many medicinal plants and their parts are frequently used to treat these diseases, and they are also suitable raw materials for the production of new synthetic agents. A review of some plant families, viz., Fabaceae, Asteraceae, Lamiaceae, etc., used in the treatment of skin diseases is provided with their most common compounds and in silico studies that summarize the recent data that have been collected in this area.

Indexed as

Plants, MedicinalSkin DiseasesAgedEthnobotanyHumansInfant, NewbornMolecular Docking SimulationPhytotherapyethnobotanygranzyme Bherbal medicinehuman leukocyte elastasemolecular dockingskin diseases

Identifiers

PMID36234737
PMCPMC9572213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.